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Background: The genetic basis of susceptibility to renal tumorigenesis has not yet been established in mouse
strains. Mouse lines derived by bidirectional phenotypic selection on the basis of their maximal (AIRmax) or minimal
(AIRmin) acute inflammatory responsiveness differ widely in susceptibility to spontaneous and urethane-induced
renal tumorigenesis. To map the functional loci modulating renal tumor susceptibility in these mice, we carried out
a genome-wide genetic linkage study, using SNP arrays, in an (AIRmax x AIRmin)F2 intercross population treated
with a single urethane dose at 1 week of age and phenotyped for renal tumors at 35 weeks of age.
Results: AIRmax mice did not develop renal tumors spontaneously nor in response to urethane, whereas in AIRmin
mice renal tumors formed spontaneously (in 52% of animals) and after urethane induction (89%). The tumors had a
papillary morphology and were positive for alpha-methylacyl-CoA racemase and negative for CD10. By analysis of
879 informative SNPs in 662 mice, we mapped a single quantitative trait locus modulating the incidence of renal
tumors in the (AIRmax x AIRmin)F2 intercross population. This locus, which we named Renal tumor modifier QTL 1
(Rtm1), mapped to chromosome 17 at 23.4 Mb (LOD score = 15.8), with SNPs rs3696835 and rs3719497 flanking the
LOD score peak. The A allele of rs3719497 from AIRmin mice was associated with a 2.5-fold increased odds ratio for
renal tumor development. The LOD score peak included the Tuberous sclerosis 2 (Tsc2) gene which has already been
implicated in kidney disease: loss of function by germline retroviral insertion is associated with spontaneous renal
tumorigenesis in the Eker rat, and heterozygous-null Tsc2(+/−) mice develop renal cystadenomas.
Conclusions: We mapped Rtm1 as a single major locus modulating renal tumorigenesis in a murine intercross
population. Thus, the AIR mouse lines can be considered a new genetic model for studying the role of germline
and somatic molecular alterations in kidney neoplastic disease.
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In humans, kidney cancer is a complex disease comprising
several different tumor types characterized by different
somatic mutations and showing different histological
features and clinical courses [1]. Risk factors include
smoking, obesity and hypertension [2]. Genetic factors
also underlie the predisposition to renal cancers, as
familial aggregations have been reported and the risk
of developing the disease for first-degree relatives of* Correspondence: olga.ibanez@butantan.gov.br
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reproduction in any medium, provided the orrenal cancer patients is 1.7- to 2.6-fold higher than
that of the general population [3]. Studies of families
with hereditary kidney cancers have permitted the
identification of mutations in several genes, including
the TSC1 and TSC2 genes linked with tuberous sclerosis,
a multi-system hamartoma syndrome (reviewed in [1]).
In addition, genome-wide association analyses in large
case–control studies have detected three loci, on chromo-
somes 2p21, 11q13.3, and 12p11.23 [4,5], associated with an
increased risk of renal cell carcinoma (RCC), the most
common renal cancer in humans. Despite this progress,
there is still much to unravel about the genetic susceptibility
to this heterogeneous disease; the ability to study theLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
AIRmax AIRmin F1 F2
Figure 1 Percent incidence of renal tumors in AIRmax (n = 15)
and AIRmin (n = 9) mice and their F1 hybrid (n = 31) and F2
intercross (n = 662) offspring. Mice were treated with 300 mg/kg
urethane at 1 week of age and then followed until 35 weeks of age,
when animals were sacrificed.
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prove advantageous.
Until now, a mouse model suitable for studying the
genetics of the inherited predisposition to renal tumor
has not been described but, as we show here, does
already exist. We previously developed the AIRmax and
AIRmin mouse lines by phenotypically selecting, from a
heterogeneous population, mice that had either an intense
or a weak acute inflammatory response (AIR) [6]. The
phenotypes used to select these strains were the number
of infiltrated leukocytes and the protein content at the site
of inflammation induced by the subcutaneous injection of
a non-specific, non-immunogenic agent (polyacrylamide
beads) [6]. After about 20 generations of selective
breeding, AIRmax and AIRmin mouse lines presented
extreme “maximal” and “minimum” phenotypes, respectively
[7] and, at that limit, were considered to be homozygous
for the quantitative trait loci (QTL) that control the
acute inflammatory reaction. In addition to the inflamma-
tory response, AIRmax and AIRmin mice differ in their
susceptibility to several types of chemically induced tumors,
in particular in the lung, skin and colon [8-10]. For
example, adult AIRmax mice are resistant and AIRmin are
susceptible to developing lung tumors in response to ureth-
ane [9], a multiorgan carcinogen with a short half-life
(<1 h) [11]. Although the susceptibility of these mice to
kidney tumors has not yet been studied, we were motivated
to investigate their suitability as a model system for
studying renal cancer genetics, especially because in
humans the inflammatory response seems to play a role in
the prognosis of renal cancer patients [12].
In the present study, a single dose of urethane injected
in 7-day old mice induced, in addition to lung tumors,
multiple renal tumors in AIRmin mice but not in AIRmax
mice. The genetic basis for the different susceptibility of
the two lines was investigated by genome-wide SNP
genotyping followed by linkage analysis with renal
tumor incidence in the pedigree of a large (AIRmax X
AIRmin)F2 intercross population.
Results
Renal tumorigenesis in AIRmax and AIRmin mice and in
interline crosses
Untreated AIRmax mice (n = 15), when analyzed at
57 weeks of age, had no renal tumors, whereas 11 (52%)
of 21 untreated AIRmin mice had spontaneous renal
tumors at the same age. When mice pups were treated
with urethane at 7 days and followed until 35 weeks of age,
AIRmax mice remained resistant to renal tumorigenesis
and did not develop any gross kidney tumor (Figure 1). In
contrast, 8 (89%) of 9 urethane-treated AIRmin mice
developed such tumors. Susceptibility to renal tumorigenesis
was inherited as a co-dominant trait, since the incidence of
renal tumors in urethane-treated (AIRmax x AIRmin)F1 mice was 39% while that in the (AIRmax x AIRmin)F2
intercross population was 25%. No statistically significant
difference was observed in renal tumor incidence between
male and female mice in any line.
Tumor-bearing mice usually had multiple kidney tumors,
which varied in size as seen both at gross examination and
microscopically. Histopathological analysis of kidney tu-
mors in selected F2 mice revealed the occurrence of lesions
suggestive of papillary renal cell tumors, characterized by
malignant epithelial cells constituting papillae and lining
tubules (Figure 2A). Tumor-lined cysts with papillary
excrescences were also seen (Figure 2B). Immunohisto-
chemical analysis showed diffuse, marked staining for
alpha-methylacyl-CoA racemase (AMACR) (Figure 2C),
which in humans is a sensitive marker for papillary renal
neoplasms. Staining for CD10, which is a marker of clear
cell RCC and which is less frequently expressed by papil-
lary tumors, was negative in our model (Figure 2D).
In addition, we carried out real-time PCR on RNA
extracted from renal tumors and normal kidney tissue to
measure the mRNA levels of known markers of these
tumors. This analysis showed that the vimentin and
β2-microglobulin genes were upregulated in renal tumors
of F2 mice (n = 12) compared to normal renal tissue
(not shown).
One major locus controls renal tumor susceptibility in
AIR mice
Of the 693 (AIRmax x AIRmin)F2 intercross mice available,
genomic DNA and renal tumor phenotype were available
for 662 animals. These mice were genotyped using SNP
arrays representing a panel of 1449 SNPs. After quality
control filtering of the genotype data, 879 markers
(824 autosomal) resulted informative and were used
in genome-wide linkage analysis. A statistical threshold
for linkage with renal tumor incidence was determined by
Figure 2 Histological section of a papillary neoplastic proliferation of a kidney from an (AIRmax x AIRmin)F2 mouse. Panel A,
hematoxylin and eosin stained section, 40X magnification. Panel B, same section at 250X magnification. The renal tumor resulted positive for
racemase (AMACR) immunostaining (panel C, 250X magnification) and negative for CD10 immunostaining (panel D, 250X magnification).
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(LOD) score of 3.7, for α=0.05 genome-wide statistical
probabilities (10,000 permutations).
Genome-wide linkage analysis detected a single QTL
on chromosome 17, with a peak LOD score of 15.8, at
23.4 Mb (Figure 3A). The 1-LOD support interval was
11 Mb long, ranging from 18 to 29 Mb (Figure 3B). The
SNPs flanking the LOD score peak were rs3696835
(22.681 Mb) and rs3719497 (25.502 Mb). We designated
this locus Renal tumor modifier QTL 1 (Rtm1) associated
with the incidence of renal tumors induced by urethane
treatment. No other region of the genome showed a
significant or suggestive association with the phenotype.
Therefore, the Rtm1 QTL likely harbors one or more
genes with major effects in renal tumorigenesis.
Association analysis showed that, at SNP rs3719497,
the G allele inherited from AIRmax mice confers resistance
whereas the A allele from parental AIRmin was associated
with a 2.5-fold increase in odds ratio (OR) for renal tumor
development (P = 1.1 x 10-12, per allele OR = 2.5; 95%
CI, 1.9 to 3.2). The ORs associated at each genotype in
F2 mice showed a very strong association of homozygosity
or heterozygosity of the AIRmin-derived A allele with
renal tumor incidence (Figure 4). Homozygous inher-
itance of the AIRmin-derived allele at this locus
caused a ~16–fold increase in the incidence of renal
tumors (from 2.5% in heterozygotes to 30.5%). Similar
findings were observed at the rs3696835, with the
AIRmin-derived allele associated with an increased
risk of renal tumors (not shown).In the 1-LOD interval of the Rtm1 locus, between 18
and 29 Mb, 378 known or predicted genes mapa. Among
these genes, the Tsc2 gene, located within the LOD score
peak, at 24.596-24.633 Mb, seems particularly relevant,
due to its known involvement in renal tumorigenesis in
rats, humans and genetically modified mice.
Genotypes of the 662 F2 mice were also assessed for
association with the inflammatory response measured by
the number of infiltrating cells (Ncell) at the local exudates
induced by a subcutaneous injection of Bio-Gel P-100. The
LOD score thresholds for linkage of Ncell, determined by
permutation analysis, were 3.34 and 3.64, respectively, for
α=0.1 and α=0.05 genome-wide statistical probabilities
(5000 permutations). On chromosome 17, which contains
the Rtm1 locus, no loci had LOD scores above the
genome-wide thresholds (not shown). This result indicates
that Rtm1 is independent of any loci associated with the
inflammatory response.
Discussion
Our findings show that AIRmin mice carry a co-dominant
genetic susceptibility trait to renal tumorigenesis induced
by urethane. By genome-wide linkage mapping of an
(AIRmax x AIRmin)F2 intercross population, we found
that such trait is regulated by germline genetic variations
in a locus in the proximal region of chromosome 17.
Within this locus, which we named Rtm1, the A allele of
rs3719497 was associated with a 2.5-fold increase in OR
for renal tumor development; homozygous inheritance of
this allele from AIRmin mice increased the incidence of


































Figure 3 Genome-wide genetic linkage analysis of renal tumor susceptibility in 662 (AIRmax x AIRmin)F2 intercross mice. Panel A,
above the genome-wide threshold value of LOD score = 3.67 for α=0.05 (horizontal red line), a single locus on chromosome 17 was detected. Panel B,
details of chromosome 17 showing the mapping of the Rtm1 locus, with LOD score peak of 15.8, at 23.4 Mb distance from the centromere.
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unique, as no other loci modulating renal tumorigenesis
have previously been mapped in mouse crosses.
No significant linkage was found between the inflamma-
tory response and SNPs on chromosome 17. This findingindicates that the Rtm1 locus was fixed during phenotypic
selection of AIR mice, independently from loci modulating
inflammatory response phenotypes. Such a phenomenon
may be due to random genetic drift, as already proposed









Figure 4 Odds ratios (ORs) of renal tumor incidence of
(AIRmax x AIRmin)F2 mice by genotype at rs3719497 on
chromosome 17, located near the peak LOD score of genetic
linkage between renal tumor incidence and genomic variants.
At the reference genotype GG, carried by AIRmax mice, renal tumors
were observed in 4 of 163 F2 mice (2.5% incidence, reference
category). At the GA genotype, renal tumors were seen in 110 of 361
mice (30.5%; OR = 14.4; 95% CI, 6.0 – 56.6), while at the AA genotype
renal tumors were observed in 54 of 138 mice (39.1%; OR = 25.5; 95%
CI, 8.5 – 86.1). ORs and 95% CIs are reported on a logarithmic scale.
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susceptibility to chemically induced tumors [8-10],
and here we show that they also differ in susceptibility to
spontaneous tumors: in the absence of any carcinogenic
treatment, >50% of AIRmin mice developed renal tumors
at 57 weeks of age, whereas no AIRmax mouse did.
Although we did not carry out a time-course analysis of
spontaneous renal tumor incidence, we noticed that after
urethane treatment of 1-week-old AIRmin mice, renal
tumors were observed earlier (34 weeks after treatment)
and with an increased incidence (~90%) as compared to
spontaneous renal tumorigenesis in the same mouse line.
In contrast, urethane treatment did not induce renal
tumors in the genetically resistant AIRmax mice. Therefore,
it seems that a correlation exists between strain susceptibil-
ity to spontaneous and urethane-induced renal tumorigen-
esis, as has already been observed for lung tumorigenesis in
a meta-analysis of numerous inbred mouse strains [14].
Our results suggest that both spontaneous and urethane-
induced renal tumors are controlled by the same genetic
locus, i.e., Rtm1, although we cannot exclude that
additional loci may control spontaneous renal tumor
susceptibility in AIR mice.
Characterization of the renal tumors by immunohis-
tochemistry showed the expression of AMACR, a per-
oxisomal and mitochondrial enzyme involved in theβ-oxidation of branched-chain fatty acids and fatty acid
derivatives. The AMACR gene has one of the highest
expression levels in papillary RCC in humans [15].
The presence of CD10 (common acute lymphoblastic
leukemia antigen or neprilysin), on the other hand,
was not detected. This protein is a cell membrane neutral
endopeptidase which participates in the post-secretory
inactivation of inflammatory and vasoactive peptides [16].
In the diagnosis of renal tumors, CD10 is more often
positive in clear cell RCC than in papillary RCC [17].
Real-time PCR pointed to the overexpression of vimentin
and β2-microglobulin. Vimentin protein positivity has
been reported in both clear cell and papillary RCCs in
human samples [18], and β2-microglobulin overexpression
has been detected in human RCC [19].
Spontaneous renal tumors are rare in inbred mouse
strains [20,21]. One exception is the BALB/c substrain
BALB/cf/Cd, which has a 24%-70% incidence of kidney
adenocarcinomas [22,23], probably due to the insertion
of the mouse mammary tumor virus into a not yet identified
chromosomal domain that is implicated in kidney tumori-
genesis [23]. Gene disruption is also known to cause
spontaneous renal carcinoma in the Eker rat, where
an endogenous retroviral element (the rat intracisternal
A-particle) has integrated into an intron of the tumor
suppressor gene tuberous sclerosis 2 (Tsc2) [24-26]. This
intronic transposition leads to the production of aberrant
Tsc2 transcripts, causing a functional inactivation of the
Tsc2 gene which leads to renal tumorigenesis.
The murine Tsc2 gene on chromosome 17 maps to the
Rtm1 locus peak identified in this study. This gene spans
over 36.7 kb, contains 40 exons, generates a full length
transcript of 6018 bp and encodes a protein of 1742
amino acidsb. The protein, called tuberin or TSC2
(in humans), controls the mTOR (mammalian target
of rapamycin) signaling pathway [27]. Of the 1150 known
polymorphisms in this gene among inbred strainsc; four
are missense variants in exons whereas the others are found
in introns or in the upstream or downstream regions where
they might play a role in modulating transcript levels. The
gene’s genomic location and involvement in renal tumori-
genesis in the rat make Tsc2 a good candidate for the AIR
renal tumor locus. Interestingly,Tsc2(+/−) mice develop renal
cystadenomas [28]. Sequencing the Tsc2 gene in AIRmax
and AIRmin mice, as well as in mice of their F2 intercross,
may reveal polymorphisms that, by influencing Tsc2 expres-
sion or tuberin function, modulate the susceptibility of
these mice to renal tumorigenesis.
Another candidate gene that maps close to Tsc2 is the
Pkd1 gene, which encodes the transmembrane protein
polycystin-1. Mutations leading to a loss of function at
this gene cause autosomal dominant polycystic kidney
disease in both humans [29] and mouse models [30].
Polycystin-1 is involved in cell adhesion and has been
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leading to the suggestion that Pdk1 is a tumor suppres-
sor gene [31]. There is also a functional link between
Tsc2 and Pkd1: in human cells, TSC2 protein alternates
from an inactive, phosphorylated form in the cytosol
to an active, non-phosphorylated form at the plasma
membrane bound to the intracellular, carboxy-terminal tail
of polycystin-1; in this subcellular position, TSC2 protein
activates the GTPase of Rheb, resulting in the inactivation
of the mTOR pathway [27].
Conclusions
Herein, we mapped Rtm1 as a novel mouse modifier
locus of chemically induced renal tumorigenesis in pedi-
grees of non-inbred mice. This locus spans the Tsc2-Pkd1
region of chromosome 17, whose candidate genes are
involved in renal cancer in animal models and humans.
These results point to the possible involvement of polymor-
phisms in this region in the functional regulation of mouse
renal tumorigenesis. Further analysis of the complete
nucleotide sequence of the Tsc2-Pkd1 region distinguishing
the two AIR lines at the Rtm1 QTL region described in this
study will allow the identification of the functional variant
responsible for the high susceptibility to spontaneous
and urethane-induced renal tumorigenesis of AIRmin
mice and may provide insight into new modulating




AIRmax and AIRmin lines (formally designated IBut:
AIRH and IBut:AIRL, respectively, at the Institute for
Laboratory Animals Research, Washington, DC, USA)
and their crosses were developed and maintained at the
animal facilities of the Laboratory of Immunogenetics of
the Butantan Institute. For genome-wide linkage analysis,
pedigrees were obtained by intercrossing AIRmax with
AIRmin mice (both from the 48th generation of the selective
bi-directional breeding), which resulted in the generation
of 66 F1 (AIRmax x AIRmin) mice. These F1 mice
were intercrossed to generate 693 (AIRmax x AIRmin)F2
mice. Animal procedures were approved by the Institutional
Animal Care and Use Committee of Butantan Institute and
all animals received humane care according to the criteria
outlined in the “Guide for the Care and Use of Laboratory
Animals” [32].
Renal tumor induction and inflammatory response assay
To chemically induce tumors, mice pups received a
subcutaneous injection of urethane (300 mg/kg body
weight) 7 days after birth. After 2 months, the same
mice were tested for their acute inflammatory response by
subcutaneous injection of 750 μl of a sterile suspensionof 67% Bio-Gel P-100 (Bio-Rad, Hercules, CA, USA)
(53 mg dry weight/ml) in phosphate-buffered saline.
Local exudates were harvested 24 h later: the total
cell count (Ncell) was determined using Malassez
hemocytometer chambers [6].
Mice were sacrificed 240 days after urethane treatment
(i.e. at 35 weeks of age) in a CO2 chamber, and tumors
in internal organs were scored macroscopically. Sam-
ples of normal and tumor-containing kidneys were
collected for immunohistochemical analyses and RNA
extraction.
As a negative control for the chemical induction of
tumors, untreated parental AIRmax and AIRmin mice were
sacrificed at 400 days (i.e. 57 weeks of age) and examined
for the presence of spontaneous tumors.Immunohistochemistry
Tumor-containing kidneys were fixed with formalin and
embedded in paraffin. Sections (3 μm) were rehydrated
and antigens were retrieved with Tris-EDTA buffer
(pH = 9) using a PT Link instrument (Dako, Glostrup,
Denmark). Immunohistochemical analysis was done
using the EnVision FLEX kit (Dako). Briefly, after en-
dogenous peroxidase blocking, slides were incubated
in a humidified chamber for 30 min with polyclonal
antisera to either alpha-methylacyl coenzyme A
racemase or CD10 (Proteintech Group, Chicago, IL, USA)
diluted 1:50. The signal was amplified using specific
EnVision FLEX Rabbit Linker and colorimetric detec-
tion was completed with 3-3′-diaminobenzidine. Slides
were counterstained with hematoxylin and mounted with
Eukitt mounting medium (Bio-Optica, Milan, Italy).Analysis of gene expression by qRT-PCR
Total RNA was extracted from RNAlater™ preserved
kidney tumors and RNA integrity was determined in
the Agilent 2100 bioanalyzer (Agilent, Waldbronn,
Germany). Primers were designed with Primer-BLAST
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/), with
the exception of B2m, which were obtained from
PrimerBank (ID 144227219b3, http://pga.mgh.harvard.
edu/primerbank/). The 5′-3′ primer sequences were:
B2m (F CCCCACTGAGACTGATACATACG and R
CGATCCCAGTAGACGGTCTTG); Vim (F TGGTACAA
GTCCAAGTTTGC and R CTCCGGTACTCGTTTGACT)
and Ribosomal protein S29 (Rps29, F TCTACTGGAGTCA
CCCACGGAAGT and R TCAGTCGAATCCATTCAAGG
TCGC). Reactions were run in a StepOnePlus™ real-time de-
tector using the Fast SYBR® Green Master Mix (Applied
Biosystems, Foster City, CA). Relative gene expression was
calculated by the ΔΔCt method [33] using pooled normal
kidney mRNA from AIRmax mice as calibrator and Rps29 as
reference gene.
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Genomic DNA was extracted from tail tips using the E.Z.N.
A. Tissue DNA Kit (Omega Bio-Tek, Norcross, GA, USA)
and quantified by fluorimetry (Invitrogen, Carlsbad, CA,
USA). SNPs were genotyped in each mouse of the pedigree
with the BeadArray technology (Illumina, San Diego, CA,
USA), using the Mouse MD Linkage Panel, which permits
analysis of 1449 SNP loci; bead chips were read in an iScan
system (Illumina), as described [34]. Genome maps are
based on Genome assembly GRCm38, Ensembl release 71.
Statistical analysis
The search for QTLs was carried out with genome-wide
linkage analysis between genotypes and phenotypes by
interval mapping using GridQTL version 1.3.2. [35].
The significance thresholds of LOD scores for phenotype-
genotype linkages were estimated by genome-wide permu-
tation analysis. Odds ratios were calculated using logistic
analysis. P-values were two-sided.
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